We need a proper roadmap for building the 5G ecosystem
24 Oct 2018 – 10:00 | No Comment

Developing and accelerating 5G infrastructure is a key enabler for the Digital Single Market. The deployment and utilisation of 5G wireless systems is essential for the EU to remain at the forefront of global digital …

Read the full story »
Health

Energy & Environment

Circular Economy

Climate Change

Security

Home » Archive by Tags

Articles tagged with: Health

Heinz Becker MEP urges political action against Alzheimer’s disease
21 Nov 2017 – 17:45
Heinz Becker MEP urges political action against Alzheimer’s disease

We must not accept Alzheimer’s disease as a normal part of ageing. Heinz Becker MEP says national governments should continue building a “dementia-friendly” Europe by ending stigma, discrimination and isolation of patients and carers, and …

Malta’s proactive approach against Dementia
13 Nov 2017 – 15:27
Malta’s proactive approach against Dementia

Malta recently collaborated with the European Commission to convene the EU Governmental Experts Group on Dementia to discuss current and future developments in dementia treatment and care. Hon. Dr Justyne Caruana MP, Minister for Gozo …

Governments must join hands with charities in our fight against dementia
13 Nov 2017 – 15:21
Governments must join hands with charities in our fight against dementia

In our lifetimes, we’ve seen incredible progress with other serious health conditions like cancer and HIV/Aids – dementia can no longer be the underdog. Mathew Norton, Director of Policy at Alzheimer’s Research UK writes why …

‘Let’s strive to reduce inequalities in access to medicines’
14 Jul 2017 – 10:50
‘Let’s strive to reduce inequalities in access to medicines’

Increasing patient literacy and reducing inequalities in access to drugs and treatment mechanisms is crucial in fighting breast cancer in Europe. Karin Kadenbach MEP, co-chair of the European Parliament Interest Group on Access to Healthcare …

Will access to innovative cancer drugs bankrupt European healthcare?
14 Jul 2017 – 10:40
Will access to innovative cancer drugs bankrupt European healthcare?

Dr Martine J Piccart  and Dr Noam Ponde from Institut Jules Bordet make an extensive study of the European drug scenario and note that a major reform in drug development is necessary, with “risk sharing” …

Changing the policy landscape for people with metastatic breast cancer
14 Jul 2017 – 10:30
Changing the policy landscape for people with metastatic breast cancer

 Placing the issue of metastatic breast cancer firmly on the European Parliament’s agenda, Emma McClarkin MEP writes that politicians should highlight the psychosocial needs of sufferers and strive to understand their lives to ensure better …

EU institutions should engage more politically to induce change in HIV awareness
14 Jul 2017 – 10:30
EU institutions should engage more politically to induce change in HIV awareness

Nearly 122,000 are unaware of their HIV infection in Europe. To decrease the number of people who are diagnosed late or are unaware of their infection, new strategies are required to expand targeted HIV testing …

European Commission’s passionate response to AIDS
14 Jul 2017 – 10:20
European Commission’s passionate response to AIDS

Thirty years since the first cases of AIDS were reported, the European Commission has been providing funding and support to several developing countries across the globe. Neven Mimica, European Commissioner for International Development and Cooperation …

Optimising prostate cancer care, providing patients with best outcomes
14 Jul 2017 – 10:07
Optimising prostate cancer care, providing patients with best outcomes

Innovative genomic-based diagnostic technologies can help patients and healthcare professionals to assess risk and personalise treatment. Claire Takizawa and Juliette Plun-Favreau from Genomic Health explain why barriers to equal access should be urgently addressed
Prostate cancer …

‘Harmonised reimbursement approach key to reducing treatment inequalities’
14 Jul 2017 – 10:07
‘Harmonised reimbursement approach key to reducing treatment inequalities’

Personalised breast cancer treatment for patients in Europe should be a priority, however a discordant reimbursement process means that many cannot access vital tests to prevent under or over treatment. Dr Marjolaine Baldo, EMEA Commercial …